News

Back

TheraVet announces positive safety and efficacy results for VISCO-VET in canine osteoarthritis

September 8th 2021

BSCB Dev

TheraVet, a pioneering company in the management of osteoarticular diseases in pets, today announces positive safety and efficacy results of its PoC (Proof-of-Concept) clinical study assessing VISCO-VET in canine osteoarthritis.

Read Pdf